Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity
Status:
COMPLETED
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
Although the number of wet AMD patients with the better visual acuity is increasing, the visual improvement in patients with the better vision may not be so significant after anti-vascular endothelial growth factor (VEGF) treatments because of 'ceiling effect'. The aim of current study is to investigate the improvement of visual function after aflibercept treatments using microperimetry in wet AMD patients with the better baseline visual acuity (≥20/40).